Planning

Q Fever collection of patient serum

MHRA BUYER ORGANISATION

This public procurement record has 1 release in its history.

Planning

15 Mar 2019 at 13:25

Market Engagement Notice
Summary of the contracting process

The MHRA Buyer Organisation is currently in the planning stage of a procurement process titled "Q Fever collection of patient serum". This initiative falls under the diagnostics industry category, specifically aiming to establish a human reference serum for Q fever by collecting patient serum samples. Located in the East of England, the engagement for potential suppliers will conclude on 5th April 2019, by which time interested parties must register their interest via email. A direct award may occur if no suitable submissions are received by the deadline.

This tender presents significant growth opportunities for suppliers in the medical and laboratory services sectors, particularly those with expertise in clinical chemistry and microbiological cultures. Companies capable of accessing a wide network for participant recruitment and possessing the necessary laboratory capabilities to handle and test biological samples will find this tender especially suited to their services. With potential direct award implications, those able to meet the stringent requirements outlined are encouraged to demonstrate their qualifications promptly.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

Q Fever collection of patient serum

Notice Description

The agency is planning to establish a human reference serum containing anti-C. burnetii IgG and IgM antibodies, with the objective to validate this material as a WHO international standard. To establish this human reference serum, we require the collection of serum that meets the inclusion criteria detailed below. Suppliers that can meet the requirements below are invited to register their interest for the supply and testing of serum samples for the development of a WHO standard for Q fever. Suppliers must be able to: 1. Evaluate the exact requirements for the development of a WHO standard for Q fever. To enable this in a timely fashion, the supplier should have an established network in the Q fever community to engage with 2. Identify subjects with different stages of Q fever infection (convalescing, actively infected or very recent (chronic) infection) 3. Access a large collection of banked samples from a well characterised cohort of past Q fever (exposed) patients for selection of convalescing subjects 4. Actively recruit subjects with active or very recent infection (unless already identified through recent/ongoing efforts) 5. Selected subjects should be aware that serum may be characterised and evaluated in an in vivo potency model for experimental vaccines. 6. Re-test /verify sero-positivity in selected patient to ensure fitness for purpose for this study (seropositivity confirmed by the most commonly used laboratory assays (IFA, ELISA, CFT) 7. Characterize donors with independent measures (other than serology) for confirmation of exposure to C. burnetii, such as PCR, IGRA or testing for cellular recall responses 8. Select at least 5 appropriate donors (defined in the evaluation) for large volume serum collection 9. Arrange plasmapheresis of the 5 donors 10. Prepare serum from donor samples 11. Test/arrange testing of serum samples for blood borne pathogens (HIV, HBV and HCV) 12. Supply NIBSC with a small sample, 25mL, for additional testing 13. Ship 500 ml serum samples from each donor to NIBSC The supplier should have the capability of supplying the collected and tested Q fever seropositive samples within 6 months of establishing the requirements. As far as we are aware there is only one supplier who is able to meet this very specific request. Potential suppliers if they feel they can meet the requirement should email Nawaz.habib@nibsc.org to register an interest. If no submissions of potential interest are received by close of play 5th April 2019, it is then intended to perform a direct award without competition to the sole supplier we believe can deliver the required service.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-3da44687-ed61-4130-bc6f-627217002010
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/1840c47d-5fc1-4c3f-9b96-26151d7f005c
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
Market Engagement Notice
Procurement Type
Standard
Procurement Category
Not specified
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

71 - Architectural, construction, engineering and inspection services

73 - Research and development services and related consultancy services

85 - Health and social work services

CPV Codes

33124000 - Diagnostics and radiodiagnostic devices and supplies

33141560 - Human organs

33141570 - Human blood

33159000 - Clinical chemistry system

33698100 - Microbiological cultures

71900000 - Laboratory services

73110000 - Research services

73111000 - Research laboratory services

85121200 - Medical specialist services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
15 Mar 20196 years ago
Submission Deadline
Not specified
Future Notice Date
5 Apr 2019Expired
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Planning
Lots Status
Not Specified
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
MHRA BUYER ORGANISATION
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
POTTERS BAR
Postcode
EN6 3QG
Post Town
Enfield
Country
England
Major Region (ITL 1)
TLH East (England)
Basic Region (ITL 2)
TLH2 Bedfordshire and Hertfordshire
Small Region (ITL 3)
TLH27 South West Hertfordshire
Delivery Location
Not specified
Local Authority
Hertsmere
Electoral Ward
Shenley
Westminster Constituency
Hertsmere

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-3da44687-ed61-4130-bc6f-627217002010-2019-03-15T13:25:08Z",
    "date": "2019-03-15T13:25:08Z",
    "ocid": "ocds-b5fd17-3da44687-ed61-4130-bc6f-627217002010",
    "language": "en",
    "initiationType": "tender",
    "title": "Q Fever collection of patient serum",
    "planning": {
        "milestones": [
            {
                "id": "1",
                "title": "Engagement end date",
                "type": "engagement",
                "dueDate": "2019-04-05T23:59:59+01:00"
            }
        ],
        "documents": [
            {
                "id": "1",
                "documentType": "marketEngagementNotice",
                "description": "Early engagement notice on Contracts Finder",
                "url": "https://www.contractsfinder.service.gov.uk/Notice/1840c47d-5fc1-4c3f-9b96-26151d7f005c",
                "datePublished": "2019-03-15T13:25:08Z",
                "format": "text/html",
                "language": "en"
            },
            {
                "id": "2",
                "documentType": "tenderNotice",
                "description": "MHRA bravo etendering portal Weblink",
                "url": "https://mhra.bravosolution.co.uk/web_mhra/login.html"
            }
        ]
    },
    "tender": {
        "id": "tender_163947/753517",
        "title": "Q Fever collection of patient serum",
        "description": "The agency is planning to establish a human reference serum containing anti-C. burnetii IgG and IgM antibodies, with the objective to validate this material as a WHO international standard. To establish this human reference serum, we require the collection of serum that meets the inclusion criteria detailed below. Suppliers that can meet the requirements below are invited to register their interest for the supply and testing of serum samples for the development of a WHO standard for Q fever. Suppliers must be able to: 1. Evaluate the exact requirements for the development of a WHO standard for Q fever. To enable this in a timely fashion, the supplier should have an established network in the Q fever community to engage with 2. Identify subjects with different stages of Q fever infection (convalescing, actively infected or very recent (chronic) infection) 3. Access a large collection of banked samples from a well characterised cohort of past Q fever (exposed) patients for selection of convalescing subjects 4. Actively recruit subjects with active or very recent infection (unless already identified through recent/ongoing efforts) 5. Selected subjects should be aware that serum may be characterised and evaluated in an in vivo potency model for experimental vaccines. 6. Re-test /verify sero-positivity in selected patient to ensure fitness for purpose for this study (seropositivity confirmed by the most commonly used laboratory assays (IFA, ELISA, CFT) 7. Characterize donors with independent measures (other than serology) for confirmation of exposure to C. burnetii, such as PCR, IGRA or testing for cellular recall responses 8. Select at least 5 appropriate donors (defined in the evaluation) for large volume serum collection 9. Arrange plasmapheresis of the 5 donors 10. Prepare serum from donor samples 11. Test/arrange testing of serum samples for blood borne pathogens (HIV, HBV and HCV) 12. Supply NIBSC with a small sample, 25mL, for additional testing 13. Ship 500 ml serum samples from each donor to NIBSC The supplier should have the capability of supplying the collected and tested Q fever seropositive samples within 6 months of establishing the requirements. As far as we are aware there is only one supplier who is able to meet this very specific request. Potential suppliers if they feel they can meet the requirement should email Nawaz.habib@nibsc.org to register an interest. If no submissions of potential interest are received by close of play 5th April 2019, it is then intended to perform a direct award without competition to the sole supplier we believe can deliver the required service.",
        "status": "planning",
        "classification": {
            "scheme": "CPV",
            "id": "33124000",
            "description": "Diagnostics and radiodiagnostic devices and supplies"
        },
        "additionalClassifications": [
            {
                "scheme": "CPV",
                "id": "33141560",
                "description": "Human organs"
            },
            {
                "scheme": "CPV",
                "id": "33141570",
                "description": "Human blood"
            },
            {
                "scheme": "CPV",
                "id": "33159000",
                "description": "Clinical chemistry system"
            },
            {
                "scheme": "CPV",
                "id": "33698100",
                "description": "Microbiological cultures"
            },
            {
                "scheme": "CPV",
                "id": "71900000",
                "description": "Laboratory services"
            },
            {
                "scheme": "CPV",
                "id": "73110000",
                "description": "Research services"
            },
            {
                "scheme": "CPV",
                "id": "73111000",
                "description": "Research laboratory services"
            },
            {
                "scheme": "CPV",
                "id": "85121200",
                "description": "Medical specialist services"
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "East of England",
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "suitability": {
            "sme": false,
            "vcse": false
        }
    },
    "parties": [
        {
            "id": "GB-CFS-106977",
            "name": "MHRA Buyer Organisation",
            "identifier": {
                "legalName": "MHRA Buyer Organisation"
            },
            "address": {
                "streetAddress": "NIBSC, Blanche Lane, South Mimms,",
                "locality": "Potters Bar",
                "postalCode": "EN6 3QG",
                "countryName": "England"
            },
            "contactPoint": {
                "email": "nawaz.habib@nibsc.org"
            },
            "roles": [
                "buyer"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-106977",
        "name": "MHRA Buyer Organisation"
    }
}